Literature DB >> 18047512

Sickle cell leg ulcers: a frequently disabling complication and a marker of severity.

M Halabi-Tawil1, F Lionnet, R Girot, C Bachmeyer, P P Lévy, S Aractingi.   

Abstract

BACKGROUND: Leg ulcers are a poorly known and underestimated complication of sickle cell disease (SCD), but in our experience they often appear as a severely disabling condition, associated with the most severe forms of the disease.
OBJECTIVES: To assess the characteristics, complications, repercussion on quality of life and associations of SCD ulcers.
METHODS: Case series of 20 patients followed in a French referral centre for SCD and who had previous/present leg ulcers.
RESULTS: Median ulcerated area was 12 cm2 and median time spent with ulcers was 29.5 months. Locoregional infections developed in 85%, ankle stiffness in 50% and mood disorders in 85%. Ninety per cent of patients needed analgesics, 20% being opioids. Median loss of time from work was 12.5 months. The Short Form 36 Health Survey showed physical and mental component summary scores of 41.5 and 40.7, respectively, indicating severe alteration close to that found in lung cancer or haemodialysis. Two categories of SCD leg ulcers were distinguished, defined by a 1-year duration cut off. The 'prolonged' ulcers had larger surfaces, tended to recur more frequently and led to more infection and depression. Several SCD complications were associated with leg ulcers, notably priapism, pulmonary hypertension, stroke and acute chest syndrome.
CONCLUSIONS: Leg ulcers are a major complication of SCD, given their severe consequences and frequent association with other specific organ damage, and they constitute in their 'prolonged' form a severely disabling condition that remains an important therapeutic challenge.

Entities:  

Mesh:

Year:  2007        PMID: 18047512     DOI: 10.1111/j.1365-2133.2007.08323.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  26 in total

1.  Laboratory and echocardiography markers in sickle cell patients with leg ulcers.

Authors:  Caterina P Minniti; James G Taylor; Mariana Hildesheim; Patricia O'Neal; Jonathan Wilson; Oswaldo Castro; Victor R Gordeuk; Gregory J Kato
Journal:  Am J Hematol       Date:  2011-05-31       Impact factor: 10.047

2.  Topical sodium nitrite for chronic leg ulcers in patients with sickle cell anaemia: a phase 1 dose-finding safety and tolerability trial.

Authors:  Caterina P Minniti; Alexander M Gorbach; Dihua Xu; Yuen Yi Hon; Kara-Marie Delaney; Miles Seidel; Nitin Malik; Marlene Peters-Lawrence; Carly Cantilena; James S Nichols; Laurel Mendelsohn; Anna Conrey; George Grimes; Gregory J Kato
Journal:  Lancet Haematol       Date:  2014-12-01       Impact factor: 18.959

3.  Topical fentanyl stimulates healing of ischemic wounds in diabetic rats.

Authors:  Mihir Gupta; Tasneem Poonawala; Mariya Farooqui; Marna E Ericson; Kalpna Gupta
Journal:  J Diabetes       Date:  2015-01-15       Impact factor: 4.006

Review 4.  Imaging review of sickle cell disease for the emergency radiologist.

Authors:  Shenise N Gilyard; Scott L Hamlin; Jamlik-Omari Johnson; Keith D Herr
Journal:  Emerg Radiol       Date:  2020-07-31

5.  TRV: a physiological biomarker in sickle cell disease.

Authors:  Gregory J Kato
Journal:  Pediatr Blood Cancer       Date:  2011-12-16       Impact factor: 3.167

6.  Clinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patients.

Authors:  Salam Alkindi; Said S Almufargi; Anil Pathare
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-06

7.  Experience with vacuum-assisted closure device in the management of benign chronic leg ulcers.

Authors:  Bc Jiburum; Ko Opara; Ic Nwagbara
Journal:  J West Afr Coll Surg       Date:  2011-01

Review 8.  Priapism in sickle-cell disease: a hematologist's perspective.

Authors:  Gregory J Kato
Journal:  J Sex Med       Date:  2011-05-06       Impact factor: 3.802

9.  Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia.

Authors:  Caterina P Minniti; Kara-Marie H Delaney; Alexander M Gorbach; Dihua Xu; Chyi-Chia Richard Lee; Nitin Malik; Antony Koroulakis; Matthew Antalek; Jordan Maivelett; Marlene Peters-Lawrence; Enrico M Novelli; Sophie M Lanzkron; Karen C Axelrod; Gregory J Kato
Journal:  Am J Hematol       Date:  2013-09-19       Impact factor: 10.047

10.  Leg ulcers in sickle cell disease: current patterns and practices.

Authors:  Kara-Marie H Delaney; Karen C Axelrod; Ashley Buscetta; Kathryn L Hassell; Patricia E Adams-Graves; Catherine Seamon; Gregory J Kato; Caterina P Minniti
Journal:  Hemoglobin       Date:  2013-04-19       Impact factor: 0.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.